Seth Eisenberg, ASN, RN, OCN, BMTCN, explained his research on a toilet cover for oncology nurses to potentially reduce exposure to infectious pathogens and hazardous drugs.

TLX007-CDx was approved by the FDA for PSMA-PET scanning in adult male patients with prostate cancer with suspected ...

Video content above is prompted by the following: • What are the most common adverse events associated with trastuzumab deruxtecan, and how can they be effectively identified and managed to minimize ...

Oncology nurses and APPs provide support and can help to facilitate conversations with patients and families during end-of-life care.

The addition of daratumumab (Darzalex) to lenalidomide (Revlimid) and dexamethasone (D-Rd) provided sustained progression-free survival (PFS) and overall survival (OS) benefits over Rd alone for ...

Real-World Data Back First-Line Avelumab and Axitinib in Advanced RCC ...

In myeloma treatment, acute CRS is a common but treatable AE associated with CAR T-cell therapy and bispecific antibodies, ...

The FDA has approved treatment with pembrolizumab plus trastuzumab and chemotherapy for HER2+ gastric/GEJ adenocarcinoma with PD-L1 CPS of 1 or greater. The FDA has granted traditional approval to ...

Alternating post-HCT care between specialized facilities and local cancer centers produced noninferior non-relapse mortality and similar quality of life to usual care. A shared care model after ...